Status
Conditions
Treatments
About
A single-center, double-blind, randomised, placebo-controlled parallel-group study.
Selected subjects will be randomised into active and control groups in a ratio of 1:1. Investigational products assigned will be applied on the facial skin as part of daily skin care routine. The effects will be observed during the 12-weeks of use.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
5 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Choon Fu Goh, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal